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The difference in sleep, sedentary behaviour, and physical activity between 
older adults with ‘healthy’ and ‘unhealthy’ cardiometabolic profiles: a cross-
sectional compositional data analysis approach 
Abstract  
Background: Studies have seldom used Compositional Data Analysis (CoDA) to map 
the effects of sleep, sedentary behaviour, and physical activity on older adults’ cardio-
metabolic profiles. This study therefore aimed to illustrate how sleep, sedentary 
behaviour, and physical activity profiles differ between older adult groups (60 - 89 
years), with ‘low’ compared to those with ‘high’ concentrations of endocrine cardio-
metabolic disease risk markers, using CoDA. 
Method: Ninety-three participants (55% female) wore a thigh-mounted triaxial 
accelerometer for seven consecutive free-living days. Accelerometer estimates of 
daily average hours of engagement in sedentary behaviour (SB), standing, light-
intensity physical activity (LIPA), sporadic moderate-vigorous physical activity 
(sMVPA, accumulated with bouts between 1 – 10 minutes), 10-minute moderate-
vigorous physical activity (10MVPA, accumulated with bouts ≥10 minutes), in addition 
to self-reported sleeping hours were reported. Fasted whole blood concentrations of 
total cholesterol, triglyceride, glucose, and glycated haemoglobin, and serum 
lipoprotein lipase (LPL), interleukin-6 (IL-6), and procollagen III N-terminal propeptide 
were determined. 
Results: Triglyceride concentration appeared to be highly dependent on 10MVPA 
engagement as the ‘low’ and ‘high’ concentration groups engaged in 48% more and 
32% less 10MVPA, respectively, relative to the geometric mean of the entire study 
sample. Time-use composition of the ‘low’ LPL group’s engagement in 10MVPA was 
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26% less, while the ‘high’ LPL group was 7.9% more, than the entire study sample. 
Time-use composition of the ‘high’ glucose and glycated haemoglobin groups 
appeared to be similar as both engaged in more Sleep and SB, and less 10MVPA 
compared to the study sample. Participants with a ‘low’ IL-6 concentration engaged in 
4.8% more Sleep and 2.7% less 10MVPA than the entire study sample. Time-use 
composition of the Total Cholesterol groups was mixed with the ‘low’ concentration 
group engaging in more Standing and 10MVPA but less Sleep, SB, LIPA, and sMVPA 
than the entire study sample. Conclusion: Older adults should aim to increase 
10MVPA engagement to improve lipid profile and vascular stiffness and decrease SB 
engagement to improve glucose profile. 
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Background 
 
Between 2011 and 2014, medication prescription for the prevention and 
treatment of circulatory diseases within the adult population increased 2.2 fold in 
England (1), with 62 – 95% of adults above the age of 55 years taking at least one 
prescribed drug per week for the treatment or prevention of any condition (2). These 
prescriptions included medications such as lipid lowering, anticoagulant and anti-
fibrinolytic drugs; critically, many of these drugs target metabolites that may be 
regulated by physical activity (PA) interventions (3-5). For example, in older adult 
cohorts (65 – 94 years), 3 х 60 min aerobic sessions per week, for 8 months, at 60 – 
80% of heart rate reserve was sufficient to reduce total cholesterol and triglyceride 
concentration (6). Additionally, emerging-evidence also suggests that changes in 
sedentary behaviour (SB) could affect metabolites, through physiological mechanisms 
that are different from those for PA (specifically of moderate to vigorous intensity 
[MVPA]) (7). In rodent modelling of SB, six hours of hind limb unloading in rats 
decreased oxidative skeletal muscle lipoprotein-lipase (LPL) activity by 50% relative 
to ambulatory controls, whereas, treadmill running (56 m∙min-1, 3.5 hr·day-1) did not 
increase oxidative muscle LPL activity above that of ambulatory controls but did in 
glycolytic muscle (7). It is suggested that SB targets post-transcriptional modification 
of LPL, as LPL mRNA expression remained unchanged during hind limb unloading 
(7). Even though SB and PA may act through independent mechanisms in the 
modulation of cardio-metabolic disease, ultimately, it is the end-point of the relevant 
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metabolite that is of most interest to the end-user. Therefore, it is argued that future 
studies should consider SB and PA together, not in isolation, to determine their 
cumulative effects on health status to reflect ‘real-world’ lifestyles.  
Previous approaches to Sleep, SB, LIPA, and MVPA analysis have treated 
these behaviours as independent risk factors for health status (8-10). Such isolation 
of the behaviours in statistical analysis is inappropriate, due to the co-dependent 
nature of time-use variables, and can lead to the under/overestimation of the effects 
of Sleep, SB, LIPA, and MVPA on health status (11). These issues can be overcome 
by using Compositional Data Analysis (CoDA) and presenting, for example, the 
geometric mean engagement in a behaviour (time-use component) as a standardised 
score, relative to the geometric mean of all engaged time-use components. This allows 
the standardised score of the engagement in a particular time-use composition by a 
sub-group to be presented as a log ratio, relative to the standardised score of the 
engagement in the same time-use composition intensity by the entire study sample 
(log ratio = ln[centred geometric mean of sub-group ÷ centred geometric mean of study 
sample]) (12-14). CoDA is normally used to compare the time-use composition of two 
or more groups, relative to the entire study sample and although a relatively new form 
of analysis in sleep, sedentary behaviour, and physical activity research, CoDA has 
provided interesting descriptive data. CoDA of the participants from the NHANES 
2005-06 cycle suggested those with a relatively low high-density lipid (HDL-C) 
concentration engaged in 9% less MVPA relative to the overall geometric mean 
composition. Whereas, those with a healthy HDL-C concentration engaged in 4% 
more MVPA relative to the overall geometric mean composition (12). 
The use of CoDA continues to grow within health research however, the 
majority of CoDA studies to date have focussed on adolescent to middle-age cohorts 
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(12, 13, 15-17). Studies that have applied CoDA to older adult cohorts have primarily 
focussed on adiposity, cardiorespiratory fitness, cholesterol and glucose (18, 19). 
Therefore, the aim of this study was to illustrate which time-use composition influences 
cardio-metabolic parameters in older adults (60 - 89 years) as cardiovascular-
metabolic complications are one of the leading causes of death in this age group (1). 
The objective of this study was to determine the difference in the time-use composition 
between older adults with ‘low’ and ‘high’ endocrine cardio-metabolic disease-risk 
(ECMDR) profiles using CoDA. It was hypothesised that time-use composition in the 
‘high’ ECMDR profile sub-groups would illustrate a greater engagement in SB and a 
lower engagement in PA relative to the entire study sample geometric mean, which 
has been shown in previous studies (12, 13).  
The current study fits within Research Area 3 of the VIRTUE Framework (11) 
as it addresses the need to “determine the prevalence of the optimal time-use balance 
among populations and specific population subgroups [and] identify the most common 
unhealthy time-use patterns in different populations” (11). This has been possible as 
our research group previously developed and utilised an accelerometer analysis 
package, which reported variable suitable for time-use analysis (11), thus fitting also 
within Research Area 1 of the VIRTUE Framework.”. 
Methods 
 
First Laboratory Visit 
 
The details of the first laboratory visit follows our previously published work (20, 
21). Briefly, older adults (60+ years) who did not suffer from an untreated 
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cardiovascular disease, had not sustained a mobility limiting injury within the last 3 
months, did not require a walking aid (e.g. Zimmer frame), were non-diabetic, and 
had/were not suffering from dementia or similar disease were recruited for the cross-
sectional epidemiology study, primarily from local community groups in Cheshire, 
United Kingdom, between January 2015 and June 2016. Study involvement was 
approved by the written informed consent of the participant and ethical approval was 
granted by the University Ethics Subcommittee. Participants provided hard copies of 
their most recent prescriptions to record which medications may be influencing their 
cardiovascular-metabolic disease risk, either directly or indirectly. These medications 
were categorised into blood pressure (BP) medication [mg∙day-1], lipid-lowering 
medication [mg∙day-1], directly targeting cardiovascular disease (CVD) medication 
[n∙day-1], (in)directly targeting CVD medication [n∙day-1], and inflammatory + (in)directly 
targeting CVD medication [mg∙day-1].  
 Participants were fitted with a commercially available tri-axial GeneActiv 
Original accelerometer (Activinsights Ltd, Kimbolton, UK) on the thigh of their 
dominant leg (anterior aspect at 50% of greater trochanter to femoral condyle 
distance) using two waterproof adhesive patches (Tegaderm Film, 3M, North Ryde, 
Australia). The accelerometer was worn for seven consecutive free-living days, during 
this time; participants self-reported their sleeping hours by recording the time they 
turned the lights off to go to sleep at night and what time they woke up to start their 
day within a sleep diary. The sleep diary was used to estimate the daily average 
sleeping hours of the participant, whilst the accelerometer estimated the daily average 
engagement hours for the other time-use components (see below for details).  
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 The accelerometer data was recorded at a 60 Hertz frequency and smoothed 
using 10-second epochs. In-house developed software, The Cheshire Algorithm for 
Sedentarism (CAS), was used to calculate the time spent engaging in each sleep, 
sedentary behaviour, and physical activity intensity using Residual G  (= √([standard 
deviation x axis]2 + [standard deviation y axis]2 + [standard deviation z axis]2)) cut-off 
points, which were developed from a sub-group (n = 20) of older adults from the 
current body of work (20-22). Behaviours were classified as SB or Standing by CAS if 
the participant was in the seated/reclined position or upright, respectively  (23), and 
produced a Residual G value, for at least one minute, below the SB-LIPA cut-off point 
(0.057 Residual G = 1.5 metabolic equivalent tasks). The Cheshire Algorithm for 
Sedentarism classified a behaviour as LIPA if the participant was upright and produced 
a Residual G value, for at least one minute, that was above the SB-LIPA cut-off point 
but below the LIPA-MVPA cut-off point (0.216 Residual G = 3 metabolic equivalent 
tasks). Any movements by the participant, whilst in the upright position, that produced 
a Residual G value that was equal to or above the LIPA-MVPA cut-off point, for at 
least one minute, was classified as MVPA by CAS. Moderate-to-vigorous physical 
activity was then further classified by CAS into sporadic MVPA (sMVPA, MVPA time 
accumulated using bouts that were between 1 - 10 continuous minutes), and 10-
minute MVPA (10MVPA, MVPA time accumulated using bouts of 10 continuous 
minutes or more). This splitting of MVPA was done to align with the 10-minute criterion 
in the 2011 UK physical activity guidelines for MVPA (24). Inclusion in statistical 
analyses required at least six 24-hour days of data from the accelerometer, as a result 
three participants were removed from statistical analyses owing to insufficient amount 
of data.  
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Second Laboratory Visit  
 
 Whole Blood Cardio-Metabolic Analysis 
 
Participants arrived to the laboratory in an overnight (>10 hours) fasted, 
hydrated state. Where appropriate, participants were asked to refrain from taking 
medication until testing had been completed. All participants refrained from taking 
medication prior to the completion of the laboratory tests and all provided a 10 mL 
venous blood sample. Whole blood analyses of fasting plasma glucose, total 
cholesterol, and triglycerides were performed immediately using an Accturend Plus 
(Roche Diagnostics Limited, Welwyn Garden City, UK) monitoring device and 
Accutrend test strips (Roche Diagnostics Limited, Welwyn Garden City, UK) (25). 
Whole blood analysis of glycated haemoglobin (HbA1c) was performed on a sub-
group of participants (n=33) using boronate fluorescence quenching (HbA1c 501 
device and test cartridges, HemoCue, Ängelholm, Sweden). HemoCue 501 has shown 
good reliability (Coefficient of Variation [CV] <5.0%) and validity (Bland-Altman: 4.4 
[95%CI -7.3, 16.2] mmol∙mol-1) compared to high performance liquid chromatography 
ion exchange (26).  
Remaining blood samples were stored on crushed ice for less than two hours 
before centrifugation at 1687 G for five minutes (Z380, Hermle, Gosheim, Germany). 
Serum was harvested and stored at -20 ºC in 1.00 mL aliquots (Eppendorf Ltd, 
Hamburg, Germany) until further analyses.  
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 Serum Cardio-Metabolic Analyses 
 
Commercially available enzyme-linked immunosorbent assay kits were used to 
determine the concentration of serum lipoprotein lipase (LPL) (Cell Biolabs Inc., 
California, USA), procollagen III N-terminal propeptide (PIIINP) (Biomatik, Delaware, 
USA), and interleukin-6 (IL-6) (high-sensitivity, Bio-Techne, Minnesota, USA) using a 
two-fold sample dilution. Manufacturer reported LPL intra-assay CV was 4% whereas 
it reached 13% in house. For PIIINP, manufacturer sample intra-assay CV was <10%, 
which coincided with in house data (6.5 - 9.6%). IL-6 manufacture intra-assay CV was 
7.8% whereas in house it ranged from 7.4 – 9.2%. ELISA data were derived using a 
96-well spectrophotometer (EL808, BioTek, Vermont, USA) connected to a computer 
running Gen5 v 1.11 software (BioTek, Vermont, USA). 
 
Statistical Analyses 
Demographics 
 
SPSS version 22 (IBM, New York, USA) was used for statistical analysis. 1×5 
independent analysis of variance (ANOVA) and bonferroni correction (Kruskall-Wallis 
and Mann-Whitney U for non-parametric data) was used to see whether participant 
demographics differed between lustrums of age and determine whether CoDA needed 
to be performed for age sub-groups or pooled study sample. Data are presented as 
mean (standard deviation [SD]) or median (interquartile range [IR]) if rules of 
parametricity are violated. Statistical significance was set at p<0.05. 
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Compositional Data Analysis 
 
Participants were grouped into ‘low’ or ‘high’ concentration groups for each 
cardio-metabolic parameter based on whether they were less than or equal to, or 
above the recognised threshold concentration for the respective cardio-metabolic 
marker (table 1). Where threshold concentrations from previous research could not be 
applied, the median (PIIINP) and mean (HbA1c) concentration of the study sample 
were used as the threshold. The HbA1c threshold of 6.5% (27) could not be applied 
to the study sample as the participants did not display diabetic symptoms and 
therefore every participants’ HbA1c percentages fell below 6.5%. Similarly, the 4780 
pg·mL-1 threshold (28) could not be applied as every PIIINP concentration within the 
current study was below this threshold.  
Table 1. Cardio-metabolic threshold values used to determine participant groupings into ‘low’ and ‘high’ 
endocrine concentration. 
Cardio-metabolic Parameter Threshold 
Glucose 6.0 mmol∙l-1 (27) 
Total Cholesterol 5.0 mmol∙l-1 (27) 
Triglyceride 1.7 mmol∙l-1 (27) 
HbA1c 5.29%* 
LPL 63.5 pg∙mL-1 (29) 
IL-6 2.29 pg∙mL-1 (30) 
PIIINP 229.215 pg∙mL-1* 
*Mean % HbA1c used as the threshold. Median PIIINP concentration used as the threshold. 
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Using Excel 2013 (Microsoft, Washington, USA), the geometric mean (hrs∙day-
1) was calculated for each time-use composition for the entire study sample. The grand 
geometric mean was further calculated for the entire time-use composition data (Sleep 
+ SB + Standing + LIPA + sMVPA + 10MVPA) of the entire study sample. The study 
sample data were centred (ceno) by dividing the geometric mean for each time-use 
composition by the grand geometric mean of the study sample and then dividing by 
the available time in a day (24 hours). These steps were then performed on the cardio-
metabolic parameter sub-groups (ceni) (‘low’ and ‘high’). The centred data for each 
time-use composition, for each sub-group, was divided by the centred data for the 
respective time-use composition of the entire study sample as a log ratio (ln[ceni ÷ 
ceno]). The log ratio represents the sub-group’s engagement in a time-use composition 
relative to the entire study sample’s standardised engagement in the same time-use 
composition (12, 13). 
 
 Handling Covariates 
 
Analysis of covariance (ANCOVA) was performed using SPSS version 22 (IBM, 
New York, USA) to determine whether covariates, previously shown to be associated 
with cardio-metabolic parameters (31-34) (BP medication [mg∙day-1], lipid-lowering 
medication [mg∙day-1], directly targeting CVD medication [n∙day-1], (in)directly targeting 
CVD medication [n∙day-1], and inflammatory + (in)directly targeting CVD medication 
[mg∙day-1]), influenced the concentration of the cardio-metabolic parameters within the 
current study (table 2). LPL was found to be influenced by inflammatory + (in)directly 
CVD targeting medication (p<0.05). LPL data were adjusted for the aforementioned 
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covariate and the participants were regrouped before CoDA was performed. No other 
cardio-metabolic parameters were influenced by the aforementioned covariates. 
 
Table 2. Influence of medication on cardio-metabolic parameters. 
Medication Cardio-metabolic Parameter 
 Glucose Triglyceride 
Total 
Cholesterol 
HbA1c LPL IL-6 PIIINP 
BP 0.71 0.93 0.57 0.53 0.14 0.95 0.70 
Lipid-lowering 0.36 0.47 0.84 0.63 0.46 0.81 0.53 
Directly 
targeting CVD 
0.94 0.06 0.69 0.27 0.89 0.24 0.59 
(in)directly 
targeting CVD 
0.64 0.32 0.90 0.68 0.31 0.76 0.35 
Inflammatory + 
(in)directly 
targeting CVD 
0.47 0.92 0.09 0.19 0.00* 0.71 0.88 
Data presented as p value. * Bold - Covariate has a significant effect on a cardio-metabolic 
endocrine parameter concentration (p<0.05). 
 
 Handling ‘Essential’ Zeros  
 
Within CoDA, there are rounded zeros, which represent data that could not be 
measured due to the sensitivity of the equipment used, and there are essential zeros, 
which represent real values for a parameter. In the current study, essential zeros were 
common in time-use composition data, as many participants did not engage in 
10MVPA. It is not possible to log transform zeros or calculate geometric means, 
therefore they need to be accounted for so they still carry weight in the analyses. One 
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method is to remove all the participants who have essential zero data, which has been 
performed in previous studies (12, 13). However, given the sample size of the current 
study (n=93), removal of participants would severely reduce the power of the study 
and thus, is not deemed an appropriate approach. Therefore, 0.1 was added to every 
data point, then 0.1 was subtracted from the geometric mean calculations (35) so the 
essential zeros still carried weight in the analysis.  
 
 Sleep, Sedentary Behaviour, and Physical Activity Co-dependence 
 
To determine the co-dependence between time-use components, a variation 
matrix was used. A variation matrix displays the variance in the study samples’ log-
ratios for each time-use composition comparison (Additional File 1, Table 1). A 
variance close to zero would imply the amounts of time spent in the corresponding 
behaviours are highly proportional and therefore, suggest a change in engagement of 
one of those time-use compositions would likely result in a change in engagement in 
the corresponding time-use composition.  
 
 
Results 
 
The demographics of the 93 older adults who participated in the study (73.6 
[7.17] years, 55% female) are displayed in table 3. Notably, there was no difference 
between lustrum age groups for any of the cardio-metabolic, time-use composition, or 
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covariate parameters. This therefore allowed follow up CoDA with pooled data. For 
results on the variation matrix of time-use components please see Additional File 1,  
table 1. 
Table 3. Participant demographics displayed per lustrum of age. Data presented as Mean(SD), 
Median(IR), or geometric mean. 
Please insert Table 3 here. 
 
Whole Blood Cardio-Metabolic Parameters 
 
The time-use composition for ‘low’ and ‘high’ whole blood cardio-metabolic 
parameter sub-groups is displayed in figure 1A-D. Triglyceride concentration appears 
to be highly dependent on 10MVPA engagement as the ‘low’ triglyceride concentration 
group engaged in 48% more 10MVPA relative to the geometric mean of the entire study 
sample (figure 1A). It also suggests that reducing 10MVPA engagement may result in 
a change to a ‘high’ triglyceride profile more readily than the opposite. Indeed those 
with a ‘high’ triglyceride concentration only engaged in 32% less 10MVPA than the 
geometric mean of the entire study sample, whereas those with a ‘low’ triglyceride 
concentration required a 48% greater engagement in 10MVPA compared to the entire 
study sample (figure 1A). It appears that differences in total cholesterol profile may be 
influenced by most time-use components as those with a ‘low’ total cholesterol profile 
engaged in less sleep (3.0%), SB (2.9%), LIPA (7.1%), sMVPA (6.0%), and more 
standing (7.9%) and 10MVPA (4.4%) than the entire study sample. The opposite time-
use composition was true for the ‘high’ total cholesterol concentration group (figure 
1B). The composition of the ‘high’ glucose and HbA1c groups appeared to be similar 
as both engaged in more sleep and SB, and less PA (excluding sMVPA) compared to 
the entire study sample (figure 1C-D). 
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Please insert Figure 1 here. 
 
Serum Cardio-Metabolic Parameters 
 
Before correcting for covariate effects, LPL was heavily influenced by 10MVPA, 
with a large difference in engagement compared to the entire study sample (‘low’ LPL: 
27% less 10MVPA, ‘high’ LPL: 11% more 10MVPA) (figure 2A). Whereas the difference 
from the entire study sample for the other time-use components did not exceed 2.2% 
(figure 2A). Following normalisation for inflammatory + (in)directly targeting CVD 
medication, the ‘low’ LPL group’s engagement in 10MVPA was 26% less while the 
‘high’ LPL group was 7.9% more than the entire study sample (figure 2B). Sleep 
appeared to be a main determinant of IL-6 concentration as those in the ‘low’ and 
‘high’ IL-6 group engaged in 4.8% more and 3.1% less sleep compared to the entire 
study sample, respectively. Whereas the other time-use components had a lower 
difference in engagement compared to the entire study sample (figure 2C). The results 
suggest that bouts of MVPA above 10 mins are sufficient to stimulate an inflammatory 
response as the ‘high’ IL-6 group engaged in 2.7% more 10MVPA and 2.2% less 
sMVPA compared to the entire study sample (figure 2C). PIIINP followed a similar 
composition to IL-6, with sleep displaying the greatest difference from the entire study 
sample in both ‘low’ (6.2%) and ‘high’ (5.9%) groups compared to the other time-use 
components.  
Please insert Figure 2 here. 
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Discussion 
 
The findings of this study confirmed our hypothesis as time-use composition in 
the ‘high’ ECMDR sub-group illustrated a greater engagement in SB and a lower 
engagement in PA relative to the entire study sample geometric mean. Whereas the 
‘low’ ECMDR sub-group engage in more PA and less SB relative to the entire study 
sample geometric mean which, in agreement with previous studies (12, 13). However, 
the hypothesis was not confirmed for IL-6 and PIIINP (when a median grouping 
threshold was used), as participants within the ‘high’ sub-groups in fact engaged in 
less SB and more PA. 
 
Lipoprotein – LPL Axis 
 
Lipoprotein lipase was one of the first identified cardio-metabolic markers to 
illustrate “independent” effects of SB and MVPA (7). It was suggested that prolonged 
SB targets oxidative skeletal muscle LPL activity whereas; MVPA appears to primarily 
target glycolytic muscle LPL activity (7). LPL is responsible for the hydrolysis of 
triglyceride into glycerol and fatty acid. Pre-heparin serum LPL (measured in the 
current study) primarily represents inactive LPL as a dimer bound to isolated remnant 
lipoproteins (36), which, in the presence of active LPL, augments triglyceride 
hydrolysis and the uptake of very low-density lipoproteins and cholesterol esters (37). 
Therefore, reduced serum LPL concentration, similar to muscle LPL activity, may lead 
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to increased circulating triglyceride concentration (38). The comparison of time-use 
composition between triglyceride and LPL groups supports the LPL-triglyceride-PA 
complex as those in the ‘high’ LPL concentration and ‘low’ triglyceride concentration 
groups both displayed a greater engagement in 10MVPA (7.8% and 48.4%, 
respectively) compared to the entire study sample. In addition, 10MVPA had the 
greatest difference from the entire study sample, compared to the other time-use 
components, for both LPL and triglyceride, suggesting that these cardio-metabolic 
markers are influenced more by 10MVPA rather than any other time-use composition. 
This finding supports that of a previous SB break study, which found 30 mins of MVPA 
(which would be classified as 10MVPA in the current study) maintained plasma 
triglyceride concentration (relative to baseline) following ingestion of a high fat meal 
(35%) (39). In addition, Engeroff, Füzéki (39) reported that short bouts of MVPA 
(representing sMVPA in the current study) were not sufficient to prevent an increase 
in triglyceride concentration following meal ingestion. This was also notable in the 
present study, as engagement in sMVPA in the ‘low’ and ‘high’ triglyceride groups only 
deviated 2.3% and 1.9% from the entire study sample, respectively, suggesting that 
sMVPA has little influence on circulating triglyceride levels.  
The pattern of time-use composition for total cholesterol is not as clear within 
the current study. This is likely due to total cholesterol containing lipoproteins that have 
opposite responses to inactivity. Both triglyceride and low-density lipids (LDL-C) 
increase in concentration, whereas high-density lipids (HDL-C) decrease in 
concentration, during detraining (38). Therefore, it is difficult to ascertain 
whether/which behaviour(s) are affecting LDL-C and HDL-C profile. Future research, 
should conduct CoDA with total cholesterol segregated into HDL-C and LDL-C to 
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provide a more precise understand of the effects of sleep, sedentary behaviour, and 
physical activity. 
Overall, our results suggests that engagement in 10MVPA influences 
triglyceride concentration by possibly targeting LPL pathways. This finding advocates 
the need for older adults to be ‘physically active’ in terms of attaining sufficient 
10MVPA, as defined in the UK government PA guidelines, especially as LPL is already 
reduced in older adults, compared to young adults (40). 
 
Glucose Metabolism 
 
The prevalence of physical inactivity and SB, even in acute episodes, has a 
marked influence on insulin insensitivity and subsequently on reduced glucose uptake 
(41-43), predominantly in skeletal muscle tissue (44). Our results support this concept 
as those with a ‘high’ glucose concentration engaged in more sleep and SB, and less 
PA (excluding sMVPA), compared to the entire study sample. This increased 
circulating glucose concentration is thought to be due to the reduced translocation of 
glucose transporter type 4 (GLUT4) to the skeletal muscle cell membrane (45) and 
reduced expression of carbohydrate metabolism genes during bouts of reduced 
muscle contractile activity (Sleep and SB) such as, cytoplasmic dynein light chain 1 
(DYNLL1) (46) which, plays a role in GLUT4 translocation (47). Our results may also 
suggest that habitual higher SB and lower PA engagement can have a chronic effect 
on glucose homeostasis, as participants with a ‘high’ HbA1c percentage also engaged 
in more sleep and SB, and less 10MVPA, compared to the entire study sample (with 
other PA apparently having little effect on HbA1c), when a mean HbA1c percentage 
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grouping threshold was used. HbA1c represents a 1-3 month average of blood glucose 
concentration (48) and can be used in the diagnosis of diabetes mellitus if blood tests 
exceed 6.5%. The results of the current study are consistent with previous findings in 
older English adult populations (≥ 60 years), which found HbA1c percentage increased 
as objective SB time increased from 8.45 – 9.52 hrs∙day-1 to >9.52 hrs∙day-1 (5.8 [0.8], 
6.0 [0.8]%, p=0.01, respectively) and reduced (0.13% [95%CI -0.24, -0.03]) per 0.5 
hrs∙day-1 increase in MVPA engagement (49). Interestingly, in line with our results, 
Stamatakis, Davis (49) also reported that LIPA was not associated with HbA1c. Our 
results therefore support that PA has to be of at least moderate intensity in order to 
maintain increased insulin sensitivity and subsequently glucose uptake, post-exercise 
(50). 
 Overall, the current study suggests that reduced SB and increased PA could 
lead to acutely reduced blood glucose concentration in older adults. However, to 
maintain a ‘healthier’ chronic glucose homeostasis, PA may have to be of a moderate-
vigorous intensity. Therefore, we urge older adults to minimise SB engagement and 
attain a ‘physically active’ lifestyle to increase the likelihood of a ‘healthy’ glucose 
profile.  
 
Inflammation and Vascular Stiffness 
 
In older adults, IL-6 serum concentration is greater compared to young adults 
(51) and is associated with an increased risk of CVD (52). The current study suggested 
that a greater engagement in sleep and SB could be beneficial towards the reduction 
in inflammation as those with a ‘low’ IL-6 concentration engaged in 4.8% and 3.8% 
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more sleep and SB, respectively, compared to the entire study sample. This is in 
agreement with previous older adult findings, which suggested that IL-6 concentration 
reduced by 2.0 pg∙mL-1 with a >1.5 hour reduction in total awake time (53). However, 
it was previously illustrated that an hour increase in SB could increase IL-6 by 0.24 
(95%CI 0.13, 0.35) pg∙mL-1 in older adults (54). The discrepancies between Henson, 
Yates (54) and the current study may lie in the type of analysis. Henson, Yates (54) 
used a multiple linear regression model, which does not account for the influence of 
other behaviour(s) on IL-6 in the same way that CoDA does, and may under-estimate 
the magnitude and direction of associations, when all other time-use compositions are 
not accounted for (15). It is thought that increases in serum IL-6 is a result of increased 
IL-6 concentration within the muscle, which occurs during repeated muscular 
contraction (55). Therefore, it is possible to postulate that an elevated amount of sleep 
engagement may be necessary for older adults to manage the inflammatory response, 
as reduced engagement in sleep is associated with an increase in IL-6 concentration 
and subsequently increased pain ratings within healthy middle-aged adults (56). This 
relationship between pain and IL-6 may also explain why the ‘low’ IL-6 group engage 
in more SB as qualitative evidence stated that older adults’ main determinant for 
engaging in SB is to reduce sensations of pain (57). However, given that those within 
‘high’ ECMDR groups (total cholesterol, triglyceride, glucose, and HbA1c) appear to 
engage in more SB, compared to the entire study sample, within the current study; it 
would be advised that older adults engage in more sleep than SB to improve IL-6 
profile. 
Increased PIIINP concentration is a marker of vascular stiffness in older adults 
(28). Within sleep, sedentary behaviour, and physical activity research, there is an 
apparent lack of investigations into changes in PIIINP with sleep, sedentary behaviour, 
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and physical activity (excluding resistance training). To the author’s knowledge, only 
one study exists, which suggested 10-weeks of LIPA and MVPA were not sufficient to 
cause a change in middle-older adults’ (51 – 71 years) PIIINP concentration (58). Our 
results suggest that those with a ‘low’ PIIINP concentration engage in a longer duration 
of all time-use compositions (excluding 10MVPA), most noticeably sleep, compared to 
the study sample and vice versa for the ‘high’ PIIINP group, when a median 
concentration grouping threshold is applied. The current study, therefore suggests that 
future research should examine the associations between sleep, sedentary behaviour, 
and physical activity and PIIINP in older adults to confirm or refute whether sleep, 
sedentary behaviour, and physical activity interventions can help reduce vascular 
stiffness through PIIINP pathways. 
Public Health Implications 
The key findings of this study suggest that older adults who have a healthy 
cholesterol and glucose profile engage in more 10MVPA and less SB than the entire 
study sample, respectively. This adds to the evidence base which supports the 
inclusion of the 10-minute threshold within the UK moderate intensity PA guideline. 
However, given such a low percentage of older adults achieve the moderate intensity 
PA guidelines (when measured with accelerometery) (59), our secondary finding offers 
hope that older adults could be able to improve health status by reducing SB, possibly 
a more palatable option for the population and recommended in the 2019 Chief 
Medical Officers’ UK Physical Activity Guidelines (60). Recently, physical activity 
guidelines for Canada and Australia have moved to considering 24-hour time-use 
composition for children and young people. As CoDA research continues to grow 
within adult-older adult populations, it appears likely that there will also be a shift to 
24-hour guideline, which will provide end-users with a variety of options to improve 
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their health-status and thus partially remove the more common one-size fits all 
approach physical activity guidance.  
There appeared to be a pattern across ECMDR variables where a sub-group who 
engaged in more 10MVPA also engaged in less sMVPA and vice versa. It seems 
unlikely that this apparent pattern between sMVPA and 10MVPA is due to co-
dependence as the variation matrix suggested a low co-dependence. Furthermore, 
without, any direct insight through an experimental manipulation of the two time-use 
components, it is difficult to put forward a definitive argument to explain why sMVPA 
and 10MVPA appear to have opposing relationships with cardiometabolic health 
markers. We can only speculate that some markers are upregulated by the HIIT (high 
intensity interval training) type stimulus (sMVPA) and downregulated by the more 
continuous type of stimulus (10MVPA), whilst other markers show the opposite 
sensitivity. In our data pooling, we categorised activities by threshold so it may be that 
the absolute amount of energy utilisation may have been higher within the MVPA 
spectrum in the sMVPA bouts, and lower within this MVPA spectrum in the 10MVPA 
bouts. In this event, the fuel utilisation (hence endocrine) profiles of sMVPA and 
10MVPA would differ significantly (61). 
Study Strengths & Limitations 
 The strengths of the study include: the use of an ‘objective’, posture recognising 
accelerometer that utilised older adult-relevant sleep, sedentary behaviour, and 
physical activity intensity cut-off points from SB through to MVPA. In fact, these cut-
off points were developed using a sub-sample of the current study’s participants. 
Another strength is the use of CoDA, which took into account the co-dependence of 
sleep, sedentary behaviour, and physical activity; and a third strength, the application 
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of time-use composition within older adult populations, which has seldom been carried 
out.” 
Nonetheless, the main limiting factor of the current study is the sample size, which 
constrained the analyses to descriptive group comparisons rather than the more 
statistically powered compositional regression analysis. Although, the current study 
provided descriptive comparisons of the time-use composition of ‘healthy’ and 
‘unhealthy’ sub-groups, the findings are limited to our sample of participants. Future 
research is needed with larger sample sizes, statistical difference testing, and 
longitudinal data from older adults to provide a comprehensive evidence base for 
generalisation at a population level. Whilst our study sample was too small to do this, 
and previous studies similar to ours did not attempt this either (12, 13), we would 
recommend that future studies using larger sample size should statistically determine 
the significance of differences between sleep, sedentary behaviour, and physical 
activity of the healthy compared to unhealthy groups. It is possible that the differences 
look large but are actually not statistically significant. Such an approach would ideally 
utilise a modification of the bootstrapping method as used in previous work (14). 
 
Conclusion 
 
CoDA revealed that all time-use components play a role in the maintenance of 
cardio-metabolic profile. For a ‘healthy’ lipid profile, our results suggested that older 
adults should attain a ‘physically active’ status, as 10MVPA engagement was greater 
in the ‘high’ LPL concentration group and subsequently greater in the ‘low’ triglyceride 
concentration group. For glucose homeostasis, the current study recommended that 
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older adults should reduce their engagement in SB by engaging in PA. In addition, it 
was suggested that being ‘physically active’ may contribute to chronic glucose 
homeostasis, as shown by the HbA1c results. Finally, a 4.8% (approximately 25 
minsday-1, based on the geometric mean of sleep for our study sample) increase in 
the amount of sleep engagement may be essential for older adults to reduce 
inflammation, especially in episodes of pain, which has been associated with 
increasing IL-6 concentration.  
Overall, the current study recommends that older adults should aim to be 
‘physically active’ by engaging in prolonged bouts of MVPA. However, in the remaining 
hours of the day, they should aim to reduce SB (in spite of the apparent benefit for IL-
6), where possible (to minimise pain), by engaging in low intensity PA (standing and 
LIPA), as these behaviours are highly co-dependent. 
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Figure Legends 
 
Figure 1. Compositional geometric mean bar plots displaying the difference in time-use composition 
between ‘low’ and ‘high’ cardio-metabolic parameter sub-groups. A) triglyceride (n ‘low’: 39, ‘high’: 50) 
30 
 
B) total cholesterol (n ‘low’: 30, ‘high’: 59), C) glucose (n ‘low’: 57, ‘high’: 32), and D) HbA1c (n ‘low’: 13, 
‘high’: 20). A positive Log Ratio indicates that a group engaged in more of a behaviour, in comparison 
with the entire study sample. A negative Log Ratio indicates that a group engaged in less of a behaviour, 
in comparison with the entire study sample. 
 
Figure 2. Compositional geometric mean bar plots displaying the difference in time-use composition 
between ‘low’ and ‘high’ cardio-metabolic parameter sub-groups. A) LPL (n ‘low’: 26, ‘high’: 57), B) LPL 
normalised for inflammatory + CVD (in)directly targeting medication (n ‘low’: 21, ‘high’: 55), C) IL-6 (n 
‘low’: 33, ‘high’: 52), and D) PIIINP (n ‘low’: 36, ‘high’: 37). A positive Log Ratio indicates that a group 
engaged in more of a behaviour, in comparison with the entire study sample. A negative Log Ratio 
indicates that a group engaged in less of a behaviour, in comparison with the entire study sample. 
 
 Age Group (years) 
Variable 
n 
Female (%) 
Pooled 
93  
55 
60 – 65 
10  
90 
66 – 71 
19  
47 
72 – 77 
31  
54 
78 – 83 
24  
54 
84+ 
9  
33 
Covariates 
Directly CVD Meds  
(n∙day-1)† 
1.17  
(1.52) 
0.30  
(0.48) 
0.74  
(1.37) 
1.39  
(1.61) 
1.39  
(1.53) 
1.78  
(1.92) 
(In)directly CVD Meds  
(n∙day-1)‡ 
1.62  
(1.81) 
0.70  
(0.67) 
1.05  
(1.51) 
1.81  
(1.97) 
2.04  
(1.92) 
2.11  
(1.96) 
Inn+ (In)directly 
CVD Meds  
(mg∙day-1)¥ 
157.86 
(486.49) 
293.40  
(797.89) 
54.71  
(73.39) 
93.19  
(293.99) 
136.67  
(323.71) 
494.88  
(1085.38) 
BP Meds  
(mg∙day-1) 
9.81  
(50.79) 
3.50  
(6.73) 
5.47  
(13.29) 
2.35  
(4.89) 
8.05  
(16.71) 
53.00  
(154.35) 
Lipid-Lowering Meds 
(mg∙day-1) 
8.12  
(16.58) 
11.00  
(16.63) 
9.41  
(15.60) 
3.57  
(10.96) 
13.33  
(23.09) 
4.44  
(13.33) 
Cardio-metabolic Parameters 
Triglyceride  
(mmol∙l-1) 
1.77  
(0.81)m 
2.09  
(0.86)m 
1.51  
(0.84)m 
1.73  
(0.68)m 
1.88  
(0.56)m 
1.89  
(0.57)m 
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Total Cholesterol  
(mmol∙l-1) 
5.44  
(1.39)m 
6.06  
(0.95) 
5.64  
(1.08) 
5.45  
(1.07) 
5.64  
(0.89) 
5.27  
(0.66) 
Glucose  
(mmol∙l-1) 
5.72  
(1.10)m 
5.81  
(0.81)m 
5.85  
(1.35)m 
5.60  
(1.33)m 
5.65  
(1.38)m 
6.00  
(1.11)m 
HbA1c  
(%) 
5.29  
(0.31) 
5.18  
(0.22) 
5.30  
(0.22) 
5.34  
(0.36) 
5.24  
(0.33) 
5.38  
(0.32) 
LPL  
(pg∙mL-1) 
113.02 
(147.80)m 
174.35  
(277.28)m 
119.13  
(127.16)m 
83.41  
(123.97)m 
117.88  
(147.07)m 
247.58  
(332.56)m 
IL-6  
(pg∙mL-1) 
2.72  
(2.77)m 
3.11  
(1.85)m 
2.39  
(2.85)m 
2.55  
(3.29)m 
2.36 
(2.98)m 
4.14  
(6.00)m 
PIIINP  
(pg∙mL-1) 
229.21 
(247.97)m 
205.05  
(239.21)m 
229.21  
(208.30)m 
316.92  
(228.81)m 
167.19  
(248.76)m 
256.99  
(406.27)m 
       
sleep, sedentary behaviour, and physical activity parameters 
Sleep  
(hrs∙day-1) 
8.43  
(0.77) 
8.40g 
7.88  
(0.83) 
7.84g 
8.49  
(0.53) 
8.48g 
8.41  
(0.73) 
8.35g 
8.62  
(0.79) 
8.58g 
8.50  
(1.04) 
8.45g 
SB  
(hrs∙day-1) 
9.65  
(1.33) 
9.56g 
9.81  
(1.31) 
9.73g 
9.34  
(1.38) 
9.25g 
9.61  
(1.36) 
9.53g 
9.59  
(1.29) 
9.51g 
10.49  
(1.15) 
10.44g 
Standing  
(hrs∙day-1) 
1.09  
(0.41) 
1.02g 
1.19  
(0.30) 
1.14g 
1.16  
(0.43) 
1.08g 
1.11  
(0.39) 
1.03g 
1.08  
(0.43) 
1.00g 
0.89  
(0.43) 
0.81g 
LIPA  
(hrs∙day-1) 
1.97  
(0.63) 
1.86g 
2.11  
(0.49) 
2.05g 
1.86  
(0.59) 
1.78g 
2.06  
(0.63) 
1.95g 
1.99  
(0.68) 
1.88g 
1.73  
(0.77) 
1.57g 
sMVPA  
(hrs∙day-1) 
2.57  
(0.64) 
2.49g 
2.68  
(0.58) 
2.62g 
2.86  
(0.56) 
2.80g 
2.55  
(0.59) 
2.49g 
2.53  
(0.69) 
2.42g 
2.07  
(0.67) 
1.96g 
10MVPA  
(hrs∙day-1) 
0.08  
(0.20)m 
0.06g 
0.06  
(0.16)m 
0.07g 
0.15  
(0.29)m 
0.13g 
0.08  
(0.21)m 
0.05g 
0.09  
(0.22)m 
0.07g 
0.07  
(0.13)m 
0.03g 
10MVPAᵜ  0.48  0.53  0.47  0.54  0.39  0.28  
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(hrs∙day-1) (0.36) 
0.40g 
(0.30) 
0.43g 
(0.22) 
0.43g 
(0.51) 
0.43g 
(0.17) 
0.35g 
(0.09) 
0.27g 
† Participants are currently prescribed an amount of medication that reduces the risk or treats CVD (i.e. statins, 
warfarin). ‡ Participants are currently prescribed a medication that may affect the cardiovascular system either 
directly or as a side effect. ¥ Participants are currently prescribed a medication that may affect the cardiovascular 
system either directly or as a side effect, including inflammatory medication. ᵜ Excluding 49 participants who 
accumulated < 10 minutes of 10MVPA in a week (variable not used in CoDA).  m Median (IR). g Geometric mean. 
       
 
